Vimarsana
Biggest News Aggregation in the World

Page 5 - Abvc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abvc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abvc Today - Breaking & Trending Today

ABVC BIOPHARMA, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) - Vimarsana News

ABVC BIOPHARMA, INC. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders. On April 24, 2023, ABVC BioPharma, Inc. held its 2023 annual meeting of shareholders . At the Annual Meeting, the Company's... | April 24, 2023

BATM Advanced Communications (LON:BVC) Share Price Crosses Below Two Hundred Day Moving Average of $27.25 - Vimarsana News

BATM Advanced Communications (LON:BVC) Share Price Crosses Below Two Hundred Day Moving Average of $27.25

Shares of BATM Advanced Communications Ltd. (LON:BVC – Get Rating) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 27.25 ($0.34) and traded as low as GBX 22 ($0.27). BATM Advanced Communications shares last traded at GBX 23 ($0.29), with […]

Source: wkrb13.com
ABVC BioPharma (OTCMKTS:ABVC) Trading Down 1.6% - Vimarsana News

ABVC BioPharma (OTCMKTS:ABVC) Trading Down 1.6%

ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Rating)’s stock price fell 1.6% during mid-day trading on Friday . The stock traded as low as $0.60 and last traded at $0.61. 36,441 shares changed hands during mid-day trading, a decline of 96% from the average session volume of 914,569 shares. The stock had previously closed at $0.62. […]

ABVC BioPharma, Inc.: ABVC BioPharma Provides 2023 Pipeline Update - Vimarsana News

ABVC BioPharma, Inc.: ABVC BioPharma Provides 2023 Pipeline Update

FREMONT, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology

ABVC BioPharma Shares Jump After FDA Approves IND Application for BLEX 404 - Vimarsana News

ABVC BioPharma Shares Jump After FDA Approves IND Application for BLEX 404

By Chris Wack ABVC BioPharma Inc. shares more than doubled to $1.51 after the company said it was notified by the U.S. Food & Drug Administration that the Investigational New Drug... | January 5, 2023